<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="easily among people and also cause disease. HIV is the" exact="human immunodeficiency virus." post="It is the virus that can lead to acquired"/>
 <result pre="during long term virologic failure of protease inhibitor therapy in" exact="human immunodeficiency virus" post="infected adultsJ Virol200276111041111212368352 BartlettJAet al.Overview of the effectiveness of"/>
 <result pre="to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant" exact="human immunodeficiency virus" post="type 1J Virol2001753291330011238855 Blum RA (2005) HIV resistance testing"/>
 <result pre="to one amino acid substitution in the catalytic site of" exact="human immunodeficiency virus" post="type 1 reverse transcriptaseAntimicrob Agents Chemother199337223122347504909 BrummeZDongWChanKHoggRet al.Influence of"/>
 <result pre="lociJ Exp Med20052011069107515809352 ChamberlainPPRenJNicholsCEet al.Crystal structures of zidovudine- or lamivudine-resistant" exact="human immunodeficiency virus" post="type 1 reverse transcriptases containing mutations at codons 41,"/>
 <result pre="of the type III interferon familyGenes Immun200910212513118987645 DerdeynCADeckerJMSfakianosJNet al.Sensitivity of" exact="human immunodeficiency virus" post="type 1 to fusion inhibitors targeted to the gp41"/>
 <result pre="on retroviruses and opportunistic infections, San Francisco DulioustAPaulousSGuillemotLDelavalleAMBoueFClavelFConstrained evolution of" exact="human immunodeficiency virus" post="type 1 protease during sequential therapy with two distinct"/>
 <result pre="GirardMMeignierBBarre-SinoussiFet al.Vaccine-induced protection of chimpanzees against infection by a heterologous" exact="human immunodeficiency virus" post="type 1J Virol19956910623962487666524 HaagmansBLAndewegACOsterhausAThe application of genomics to emerging"/>
 <result pre="Dis20013277478211229846 HannaGJJohnsonVAKuritzkesDRet al.Patterns of resistance mutations selected by treatment of" exact="human immunodeficiency virus" post="type 1 infection with zidovudine, didanosine, and nevirapineJ Infect"/>
 <result pre="immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6" exact="human immunodeficiency virus" post="type 1 trigene vaccines alone and in combination in"/>
 <result pre="mutations, San Francisco. http://www.iasusa.org/resistance_mutations/index.html. Accessed 9 Feb 2004 IversenAKShaferRWWehrlyKet al.Multidrug-resistant" exact="human immunodeficiency virus" post="type 1 strains resulting from combination antiretroviral therapyJ Virol199670108610908551567"/>
 <result pre="with clinical and pharmacogenetic dataN Engl J Med200936075376419228618 KohlNEet al.Active" exact="human immunodeficiency virus" post="protease is required for viral infectivityProc Natl Acad Sci"/>
 <result pre="viral infectivityProc Natl Acad Sci USA19888513468646903290901 KosalaraksaPKavlickMFMarounVLeRMitsuyaHComparative fitness of multidideoxynucleoside-resistant" exact="human immunodeficiency virus" post="type 1 (HIV-1) in an in vitro competitive HIV-1"/>
 <result pre="southern African black adult carriers of the virusHepatology1997252352408985297 KuritzkesDRQuantification of" exact="human immunodeficiency virus" post="type 1 by reverse transcriptase-coupled polymerase chain reactionJ Infect"/>
 <result pre="abacavirN Engl J Med200835856865718256392 MammanoFPetitCClavelFResistance-associated loss of viral fitness in" exact="human immunodeficiency virus" post="type 1: phenotypic analysis of protease and gag coevolution"/>
 <result pre="in protease inhibitor-treated patientsJ Virol199872763276379696866 MammanoFTrouplinVZennouVClavelFRetracing the evolutionary pathways of" exact="human immunodeficiency virus" post="type 1 resistance to protease inhibitors: virus fitness in"/>
 <result pre="elicits neutralizing antibodies against laboratory-adapted but not primary isolates of" exact="human immunodeficiency virus" post="type 1. The National Institute of Allergy and Infectious"/>
 <result pre="Infect Dis199617323403488568294 Mc CutchanFEHoelscherMTovanabutraSet al.In-depth analysis of a heterosexually acquired" exact="human immunodeficiency virus" post="type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics"/>
 <result pre="Immunol200323297107 PicardVAngeliniEMaillardAet al.Comparison of genotypic and phenotypic resistance patterns of" exact="human immunodeficiency virus" post="type 1 isolates from patients treated with stavudine and"/>
 <result pre="zidovudine-resistant isolates of human immunodeficiency virusAm J Med1990888S10S2186629 RimskyLTShugarsDCMatthewsTJDeterminants of" exact="human immunodeficiency virus" post="type 1 resistance to gp41-derived inhibitory peptidesJ Virol1998729869939444991 RobertsNAMartinJAKinchingtonDet"/>
 <result pre="SchiffmanMCastlePEJeronimoJRodriguezACWacholderSHuman papillomavirus and cervical cancerLancet200737089090717826171 SchuurmanRNijhuisMvan LeeuwenRet al.Rapid changes in" exact="human immunodeficiency virus" post="type 1 RNA load and appearance of drug-resistant virus"/>
 <result pre="systems versus the Roche AmpliPrep-AMPLICOR combination for high-throughput monitoring of" exact="human immunodeficiency virus" post="LoadJ Clin Microbiol2007451244124917267632 SuppiahVMoldovanMAhlenstielGet al.IL28B is associated with response"/>
 <result pre="Van GilsMJet al.High prevalence of neutralizing activity against multiple unrelated" exact="human immunodeficiency virus" post="type 1 (HIV-1) subtype B variants in sera from"/>
 <result pre="4 Web. http://who.int/inf-fs/en/fact204.html WuTDet al.Mutation patterns and structural correlates in" exact="human immunodeficiency virus" post="type 1 protease following different protease inhibitor treatmentsJ Virol20037784836484712663790"/>
 <result pre="al.Characterization of the outer domain of the gp120 glycoprotein from" exact="human immunodeficiency virus" post="type 1J Virol20047823129751298615542649 YeeLJTangJGibsonAWet al.Interleukin 10 polymorphisms as predictors"/>
 <result pre="fitness associated with multiple Gag and Gag-Pol processing defects in" exact="human immunodeficiency virus" post="type 1 variants selected for resistance to protease inhibitors"/>
</results>
